Cargando…
P670: EARLY CYTOGENETIC OR MOLECULAR LANDMARK RESPONSE TO PONATINIB TREATMENT PREDICTS OUTCOMES IN HEAVILY PRETREATED PATIENTS WITH CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA IN PACE: 5-YEAR DATA
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428931/ http://dx.doi.org/10.1097/01.HS9.0000969584.88427.a9 |
| _version_ | 1785090588902686720 |
|---|---|
| author | Müller, Martin C. Cortes, Jorge Chuah, Charles Deangelo, Daniel Deininger, Michael Guilhot, François Hughes, Timothy Emmanuel Nicolini, Franck Pinilla-Ibarz, Javier Rea, Delphine Rosti, Gianantonio Shah, Neil P. Talpaz, Moshe Lu, Vickie Padukkavidana, Thihan Kantarjian, Hagop |
| author_facet | Müller, Martin C. Cortes, Jorge Chuah, Charles Deangelo, Daniel Deininger, Michael Guilhot, François Hughes, Timothy Emmanuel Nicolini, Franck Pinilla-Ibarz, Javier Rea, Delphine Rosti, Gianantonio Shah, Neil P. Talpaz, Moshe Lu, Vickie Padukkavidana, Thihan Kantarjian, Hagop |
| author_sort | Müller, Martin C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428931 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104289312023-08-17 P670: EARLY CYTOGENETIC OR MOLECULAR LANDMARK RESPONSE TO PONATINIB TREATMENT PREDICTS OUTCOMES IN HEAVILY PRETREATED PATIENTS WITH CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA IN PACE: 5-YEAR DATA Müller, Martin C. Cortes, Jorge Chuah, Charles Deangelo, Daniel Deininger, Michael Guilhot, François Hughes, Timothy Emmanuel Nicolini, Franck Pinilla-Ibarz, Javier Rea, Delphine Rosti, Gianantonio Shah, Neil P. Talpaz, Moshe Lu, Vickie Padukkavidana, Thihan Kantarjian, Hagop Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428931/ http://dx.doi.org/10.1097/01.HS9.0000969584.88427.a9 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Müller, Martin C. Cortes, Jorge Chuah, Charles Deangelo, Daniel Deininger, Michael Guilhot, François Hughes, Timothy Emmanuel Nicolini, Franck Pinilla-Ibarz, Javier Rea, Delphine Rosti, Gianantonio Shah, Neil P. Talpaz, Moshe Lu, Vickie Padukkavidana, Thihan Kantarjian, Hagop P670: EARLY CYTOGENETIC OR MOLECULAR LANDMARK RESPONSE TO PONATINIB TREATMENT PREDICTS OUTCOMES IN HEAVILY PRETREATED PATIENTS WITH CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA IN PACE: 5-YEAR DATA |
| title | P670: EARLY CYTOGENETIC OR MOLECULAR LANDMARK RESPONSE TO PONATINIB TREATMENT PREDICTS OUTCOMES IN HEAVILY PRETREATED PATIENTS WITH CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA IN PACE: 5-YEAR DATA |
| title_full | P670: EARLY CYTOGENETIC OR MOLECULAR LANDMARK RESPONSE TO PONATINIB TREATMENT PREDICTS OUTCOMES IN HEAVILY PRETREATED PATIENTS WITH CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA IN PACE: 5-YEAR DATA |
| title_fullStr | P670: EARLY CYTOGENETIC OR MOLECULAR LANDMARK RESPONSE TO PONATINIB TREATMENT PREDICTS OUTCOMES IN HEAVILY PRETREATED PATIENTS WITH CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA IN PACE: 5-YEAR DATA |
| title_full_unstemmed | P670: EARLY CYTOGENETIC OR MOLECULAR LANDMARK RESPONSE TO PONATINIB TREATMENT PREDICTS OUTCOMES IN HEAVILY PRETREATED PATIENTS WITH CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA IN PACE: 5-YEAR DATA |
| title_short | P670: EARLY CYTOGENETIC OR MOLECULAR LANDMARK RESPONSE TO PONATINIB TREATMENT PREDICTS OUTCOMES IN HEAVILY PRETREATED PATIENTS WITH CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA IN PACE: 5-YEAR DATA |
| title_sort | p670: early cytogenetic or molecular landmark response to ponatinib treatment predicts outcomes in heavily pretreated patients with chronic-phase chronic myeloid leukemia in pace: 5-year data |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428931/ http://dx.doi.org/10.1097/01.HS9.0000969584.88427.a9 |
| work_keys_str_mv | AT mullermartinc p670earlycytogeneticormolecularlandmarkresponsetoponatinibtreatmentpredictsoutcomesinheavilypretreatedpatientswithchronicphasechronicmyeloidleukemiainpace5yeardata AT cortesjorge p670earlycytogeneticormolecularlandmarkresponsetoponatinibtreatmentpredictsoutcomesinheavilypretreatedpatientswithchronicphasechronicmyeloidleukemiainpace5yeardata AT chuahcharles p670earlycytogeneticormolecularlandmarkresponsetoponatinibtreatmentpredictsoutcomesinheavilypretreatedpatientswithchronicphasechronicmyeloidleukemiainpace5yeardata AT deangelodaniel p670earlycytogeneticormolecularlandmarkresponsetoponatinibtreatmentpredictsoutcomesinheavilypretreatedpatientswithchronicphasechronicmyeloidleukemiainpace5yeardata AT deiningermichael p670earlycytogeneticormolecularlandmarkresponsetoponatinibtreatmentpredictsoutcomesinheavilypretreatedpatientswithchronicphasechronicmyeloidleukemiainpace5yeardata AT guilhotfrancois p670earlycytogeneticormolecularlandmarkresponsetoponatinibtreatmentpredictsoutcomesinheavilypretreatedpatientswithchronicphasechronicmyeloidleukemiainpace5yeardata AT hughestimothy p670earlycytogeneticormolecularlandmarkresponsetoponatinibtreatmentpredictsoutcomesinheavilypretreatedpatientswithchronicphasechronicmyeloidleukemiainpace5yeardata AT emmanuelnicolinifranck p670earlycytogeneticormolecularlandmarkresponsetoponatinibtreatmentpredictsoutcomesinheavilypretreatedpatientswithchronicphasechronicmyeloidleukemiainpace5yeardata AT pinillaibarzjavier p670earlycytogeneticormolecularlandmarkresponsetoponatinibtreatmentpredictsoutcomesinheavilypretreatedpatientswithchronicphasechronicmyeloidleukemiainpace5yeardata AT readelphine p670earlycytogeneticormolecularlandmarkresponsetoponatinibtreatmentpredictsoutcomesinheavilypretreatedpatientswithchronicphasechronicmyeloidleukemiainpace5yeardata AT rostigianantonio p670earlycytogeneticormolecularlandmarkresponsetoponatinibtreatmentpredictsoutcomesinheavilypretreatedpatientswithchronicphasechronicmyeloidleukemiainpace5yeardata AT shahneilp p670earlycytogeneticormolecularlandmarkresponsetoponatinibtreatmentpredictsoutcomesinheavilypretreatedpatientswithchronicphasechronicmyeloidleukemiainpace5yeardata AT talpazmoshe p670earlycytogeneticormolecularlandmarkresponsetoponatinibtreatmentpredictsoutcomesinheavilypretreatedpatientswithchronicphasechronicmyeloidleukemiainpace5yeardata AT luvickie p670earlycytogeneticormolecularlandmarkresponsetoponatinibtreatmentpredictsoutcomesinheavilypretreatedpatientswithchronicphasechronicmyeloidleukemiainpace5yeardata AT padukkavidanathihan p670earlycytogeneticormolecularlandmarkresponsetoponatinibtreatmentpredictsoutcomesinheavilypretreatedpatientswithchronicphasechronicmyeloidleukemiainpace5yeardata AT kantarjianhagop p670earlycytogeneticormolecularlandmarkresponsetoponatinibtreatmentpredictsoutcomesinheavilypretreatedpatientswithchronicphasechronicmyeloidleukemiainpace5yeardata |